Skip to Main Content

Preferred Drug List Changes

The following changes have been made to the Nebraska PDL. Changes are effective January 22, 2022.

Heritage Health - Nebraska Total Care 

 

Nebraska PDL Therapeutic Drug Class Change effective January 22, 2022
BRONCHODILATORS, BETA AGONIST ALBUTEROL HFA (PROAIR) (INHALATION) → PREFERRED
MOVEMENT DISORDERS INGREZZA (ORAL) → PREFERRED
OPHTHALMICS FOR ALLERGIC CONJUNCTIVITIS OLOPATADINE (PATANOL) (OPHTHALMIC) → PREFERRED
OLOPATADINE OTC (PATADAY ONCE DAILY) (OPHTHALMIC) → PREFERRED
OLOPATADINE OTC (PATADAY TWICE A DAY) (OPHTHALMIC) → PREFERRED
PAZEO (OPHTHALMIC) → NON PREFERRED
OPHTHALMICS, GLAUCOMA AGENTS ALPHAGAN P 0.15% (OPHTHALMIC)→ PREFERRED
HEMOPHILIA TREATMENT ALPROLIX (INTRAVEN) → PREFERRED
ONCOLOGY, ORAL - PROSTATE ZYTIGA (ORAL) → PREFERRED